1726 - 1750 of 9145 Results
Title
Year
-
OPENTitle: In Silico Studies Comparing the Adjuvant Therapies Approved for Parkinson’s diseaseJournal Name: Journal of Drug Delivery and TherapeuticsPublisher: Society of Pharmaceutical TecnocratsVol: 11Issue #: 3-SStart Page: 104End Page: 110Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.22270/jddt.v11i3-s.4813Best OA location URL: http://jddtonline.info/index.php/jddt/article/download/4813/3895Citation Count: 2
- Triplication of Synaptojanin 1 in Alzheimer’s Disease Pathology in Down Syndrome2022RESTRICTEDTitle: Triplication of Synaptojanin 1 in Alzheimer’s Disease Pathology in Down SyndromeJournal Name: Current Alzheimer ResearchPublisher: Bentham Science Publishers Ltd.Vol: 19Issue #: 12Start Page: 795End Page: 807Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.2174/1567205020666221202102832Citation Count: 4
- Predicting Neuropsychiatric Symptoms of Parkinson’s Disease with Measures of Striatal Dopaminergic Deficiency2021RESTRICTEDTitle: Predicting Neuropsychiatric Symptoms of Parkinson’s Disease with Measures of Striatal Dopaminergic DeficiencyJournal Name: Current Alzheimer ResearchPublisher: Bentham Science Publishers Ltd.Vol: 18Issue #: 6Start Page: 499End Page: 504Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.2174/1567205018666210827122133Citation Count: 4
- Drug Repurposing: An Emerging Tool for Drug Reuse, Recycling and Discovery2021RESTRICTEDTitle: Drug Repurposing: An Emerging Tool for Drug Reuse, Recycling and DiscoveryJournal Name: Current Drug Research ReviewsPublisher: Bentham Science Publishers Ltd.Vol: 13Issue #: 2Start Page: 101End Page: 119Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.2174/2589977513666210211163711Citation Count: 39
-
RESTRICTEDTitle: Flavaglines: Their Discovery from Plants Used in Traditional Chinese Medicine, Synthesis, and Drug Development Against Cancer and Immune DisordersJournal Name: Current Chinese ChemistryPublisher: Bentham Science Publishers Ltd.Vol: 2Issue #: 2Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.2174/2666001601666211126091737Best OA location URL: https://hal.science/hal-03806707Citation Count: 0
-
OPENTitle: Леводопа/карбідопа пролонгованого вивільнення в лікуванні хвороби ПаркінсонаJournal Name: INTERNATIONAL NEUROLOGICAL JOURNALPublisher: Publishing House ZaslavskyVol:Issue #: 3.97Start Page: 48End Page: 58Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.22141/2224-0713.3.97.2018.133682Best OA location URL: https://inj.zaslavsky.com.ua/index.php/journal/article/download/627/654Citation Count: 0
-
OPENTitle: Am I My Cousin's Keeper? A Proposal to Protect Relatives of Genetic Database SubjectsJournal Name: Indiana Health Law ReviewPublisher: IUPUI University LibraryVol: 18Issue #: 1Start Page: 1End Page: 55Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.18060/25052Best OA location URL: https://journals.iupui.edu/index.php/ihlr/article/download/25052/23545Citation Count: 3
- Relationship of Neurofilament Light (NfL) and Cognitive Performance in a Sample of Mexican Americans with Normal Cognition, Mild Cognitive Impairment and Dementia2021OPENTitle: Relationship of Neurofilament Light (NfL) and Cognitive Performance in a Sample of Mexican Americans with Normal Cognition, Mild Cognitive Impairment and DementiaJournal Name: Current Alzheimer ResearchPublisher: Bentham Science Publishers Ltd.Vol: 17Issue #: 13Start Page: 1214End Page: 1220Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.2174/1567205018666210219105949Citation Count: 20
-
OPENTitle: Development, Efficacy and Safety of Once-daily, Bedtime, Extended-release Amantadine (Gocovri®) to Treat Dyskinesia and OFF Time in Parkinson’s DiseaseJournal Name: NeurologyPublisher: Touch Medical Media, Ltd.Vol: 17Issue #: 1Start Page: 36End Page: 36Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.17925/usn.2021.17.1.36Best OA location URL: https://touchneurology.com/wp-content/uploads/sites/3/2021/07/touchNEURO_17.1_pp36-47.pdfCitation Count: 1
-
OPENTitle: Supplement (online only): Proceedings of the 14th Göttingen Meeting of the German Neuroscience Society 2021Journal Name: NeuroforumPublisher: Walter de Gruyter GmbHVol: 27Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1515/nf-2021-2003Best OA location URL: https://www.degruyter.com/document/doi/10.1515/nf-2021-2003/pdfCitation Count: 0
-
OPENTitle: Deep learning for Parkinson’s disease symptom detection and severity evaluation using accelerometer signalJournal Name: ESANN 2022 proceedingsPublisher: Ciaco - i6doc.comVol:Issue #:Start Page: 271End Page: 276Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.14428/esann/2022.es2022-107Best OA location URL: https://doi.org/10.14428/esann/2022.es2022-107Citation Count: 1
- The philosophy of Constantine the Philosopher of Nicaea2021RESTRICTEDTitle: The philosophy of Constantine the Philosopher of NicaeaJournal Name: Byzantinische ZeitschriftPublisher: Walter de Gruyter GmbHVol: 114Issue #: 1Start Page: 139End Page: 162Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1515/bz-2021-9006Citation Count: 0
- Body Mass Index, Abdominal Adiposity, and Incidence of Parkinson Disease in French Women From the E3N Cohort Study2022RESTRICTEDTitle: Body Mass Index, Abdominal Adiposity, and Incidence of Parkinson Disease in French Women From the E3N Cohort StudyJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 100Issue #: 3Start Page: e324End Page: e335Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000201468Citation Count: 17
-
OPENTitle: Teaching Video NeuroImage: “Weighing” in on an Unusual TremorJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 97Issue #: 9Start Page: e970End Page: e971Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000012141Best OA location URL: https://n.neurology.org/content/neurology/97/9/e970.full.pdfCitation Count: 2
-
OPENTitle: Quality Improvement in NeurologyJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 97Issue #: 5Start Page: 239End Page: 245Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000012198Best OA location URL: https://n.neurology.org/content/neurology/97/5/239.full.pdfCitation Count: 22
- Amyloid Precursor Protein Variant, E665D, Associated With Unique Clinical and Biomarker Phenotype2021OPENTitle: Amyloid Precursor Protein Variant, E665D, Associated With Unique Clinical and Biomarker PhenotypeJournal Name: American Journal of Alzheimer's Disease & Other Dementias®Publisher: SAGE PublicationsVol: 36Issue #:Start Page: 1533317520981225End Page: 1533317520981225Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1177/1533317520981225Best OA location URL: https://journals.sagepub.com/doi/pdf/10.1177/1533317520981225Citation Count: 8
- Update From the Foundation2021RESTRICTEDTitle: Update From the FoundationJournal Name: OTJR: Occupational Therapy Journal of ResearchPublisher: SAGE PublicationsVol: 42Issue #: 1Start Page: 8End Page: 9Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1177/15394492211059406Citation Count: 0
- Autoimmune hemolytic anemia, demyelinating relapse, and AQP1 antibodies after alemtuzumab infusion2020OPENTitle: Autoimmune hemolytic anemia, demyelinating relapse, and AQP1 antibodies after alemtuzumab infusionJournal Name: Neurology Neuroimmunology & NeuroinflammationPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 7Issue #: 3Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/nxi.0000000000000711Best OA location URL: https://nn.neurology.org/content/nnn/7/3/e711.full.pdfCitation Count: 12
-
OPENTitle: Normative vs. patient-specific brain connectivity in deep brain stimulationJournal Name: NeuroImagePublisher: Elsevier BVVol: 224Issue #:Start Page: 117307End Page: 117307Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.neuroimage.2020.117307Best OA location URL: https://doi.org/10.1016/j.neuroimage.2020.117307Citation Count: 135
-
OPENTitle: Differentiation of multiple system atrophy subtypes by gray matter atrophyJournal Name: Journal of NeuroimagingPublisher: WileyVol: 32Issue #: 1Start Page: 80End Page: 89Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1111/jon.12927Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jon.12927Citation Count: 10
-
OPENTitle: fISHing with immunohistochemistry for housekeeping gene changes in Alzheimer’s disease using an automated quantitative analysis workflowJournal Name: Journal of NeurochemistryPublisher: WileyVol: 157Issue #: 4Start Page: 1270End Page: 1283Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/jnc.15283Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jnc.15283Citation Count: 7
-
OPENTitle: Alpha‐Synuclein oligomerization and aggregation: All models are useful but only if we know what they modelJournal Name: Journal of NeurochemistryPublisher: WileyVol: 157Issue #: 4Start Page: 891End Page: 898Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/jnc.15275Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jnc.15275Citation Count: 7
- Too much for your own good: Excessive dopamine damages neurons and contributes to Parkinson's disease2021RESTRICTEDTitle: Too much for your own good: Excessive dopamine damages neurons and contributes to Parkinson's diseaseJournal Name: Journal of NeurochemistryPublisher: WileyVol: 158Issue #: 4Start Page: 833End Page: 836Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/jnc.15442Citation Count: 15
- Impairment of amacrine starburst cells and their synaptic contacts with dopaminergic cells could explain motion perception disturbances in Parkinson's disease2022RESTRICTEDTitle: Impairment of amacrine starburst cells and their synaptic contacts with dopaminergic cells could explain motion perception disturbances in Parkinson's diseaseJournal Name: Acta OphthalmologicaPublisher: WileyVol: 100Issue #: S275Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/j.1755-3768.2022.0786Citation Count: 0
- Deep learning‐based scheme to diagnose Parkinson's disease2021RESTRICTEDTitle: Deep learning‐based scheme to diagnose Parkinson's diseaseJournal Name: Expert SystemsPublisher: WileyVol: 39Issue #: 3Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/exsy.12739Citation Count: 93